Cannabix Technologies Inc (BLOZF)

[medchem]

Thank you for correcting his points. Breathtec will have a working product much before Cannabix, and will hit a bigger market. The money Breathtec makes will most certainly trickle into the Yost lab and Cannabix will indirectly benefit. A buyout of either company will be for way more than 2-3 dollars per share. If Na-NOSE trial is a success, shares would skyrocket. I see shares hitting 2-3 dollars in the next 6 months given that they have a heavily trial tested product and a government approved clinical trial that's already taking place. They received millions (Haick that is) from the European Union and have demonstrated product success. Also it is possible that Na-NOSE will get licensed by Cannabix for controlled substances as AMG mentions. But regardless, Breathtec is going to score big and the cash flow is going to boost both companies.